Results 211 to 220 of about 600,294 (239)

Multimodal Actuation and Environment Adaptive Strategies of Bio‐Inspired Micro/Nanorobots in Precision Medicine

Advanced Robotics Research, EarlyView.
An introduction for multidrive and environment‐adaptive micro/nanorobotics: design and fabrication strategies, intelligent actuation, and their applications. Various intelligent actuation approaches—magnetic, acoustic, optical, chemical, and biological—can be synergistically designed to enhance flexibility and adaptive behavior for precision medicine ...
Aiqing Ma, Han Gong, Jiacheng Ouyang, Liqi Chen, Tianfang Kang, Yiran He, Guojun Huang, Sidi Zheng, Ting Yin, Hong Pan, Lintao Cai   +10 more
wiley   +1 more source

More protein-ligand data are needed for AlphaFold-like models to enable drug discovery. [PDF]

Curr Opin Struct Biol
Singh S, Clerkin AB, Castellanos MA, Chodera JD.   +3 more
europepmc   +1 more source

Multidisciplinary cutting-edge technologies accelerating target-based drug discovery. [PDF]

J Pharm Anal
Li Y, Moaddel R, Jiang Z, Chen X.
europepmc   +1 more source

A target-guided drug repurposing strategy for antibacterial discovery. [PDF]

BMC Microbiol
Zhang D, Li H, Ye A, Lian X, Cui H, Cheng Z, Guo FB.   +6 more
europepmc   +1 more source

Deep Drug–Target Binding Affinity Prediction Base on Multiple Feature Extraction and Fusion

ACS Omega
Zepeng Li, Yuni Zeng, Mingfeng Jiang, Bo Wei   +3 more
doaj   +1 more source

The adaptive immune receptors in a big data world. [PDF]

Immunohorizons
DeKosky BJ.
europepmc   +1 more source

Application of Reinforcement Learning Techniques in De Novo Drug Design: A Systematic Literature Review. [PDF]

Health Sci Rep
Sampa MB, Aziz NHA.
europepmc   +1 more source

Leveraging conformational ensembles in allosteric drug discovery. [PDF]

Trends Pharmacol Sci
Nussinov R, Regev C, Jang H.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Germinal centers output clonally diverse plasma cell populations expressing high- and low-affinity antibodies

Cell, 2023
Adrien Sprumont, Oliver Bannard
exaly